10,11-Dihydroxy-4-methyl-6-propyl-5,6,6a,7,8,12b-hexahydro-benzo[a]phenanthridinium (4-MNP-DHX)

ID: ALA104141

PubChem CID: 10314127

Max Phase: Preclinical

Molecular Formula: C21H25NO2

Molecular Weight: 323.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN1Cc2c(C)cccc2[C@@H]2c3cc(O)c(O)cc3CC[C@H]21

Standard InChI:  InChI=1S/C21H25NO2/c1-3-9-22-12-17-13(2)5-4-6-15(17)21-16-11-20(24)19(23)10-14(16)7-8-18(21)22/h4-6,10-11,18,21,23-24H,3,7-9,12H2,1-2H3/t18-,21-/m1/s1

Standard InChI Key:  IURHNFGBYOFFDB-WIYYLYMNSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    5.1706   -1.0427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9331   -1.7572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5206   -2.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5206   -1.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7581   -1.7572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9331   -0.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7581   -0.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9331   -3.1861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6956   -2.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2831   -3.1861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5206   -3.9006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6956   -3.9006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1706   -2.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7581   -3.1861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5206    0.3863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9956   -1.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6956   -1.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4581   -3.1861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2831   -4.6150    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2831   -0.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6956    0.3863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9331    1.1007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4081   -0.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2331   -0.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5831   -1.7572    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.1081   -1.7572    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  5  1  0
  3  2  1  0
  4  6  2  0
  5  1  1  0
  6  7  1  0
  7  1  1  0
  8 14  1  0
  9  3  2  0
 10  9  1  0
 11  8  2  0
 12 11  1  0
 13  5  1  0
 14 13  1  0
 15  6  1  0
  1 16  1  0
 17  4  1  0
 18 10  1  0
 19 12  1  0
 20 21  1  0
 21 15  2  0
 22 15  1  0
 23 16  1  0
 24 23  1  0
  2  4  1  0
  3  8  1  0
 20 17  2  0
 10 12  2  0
  5 25  1  1
  2 26  1  6
M  END

Associated Targets(non-human)

Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine D1 receptor (1900 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adcy5 Adenylate cyclase type V (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine receptors; D1 & D2 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 323.44Molecular Weight (Monoisotopic): 323.1885AlogP: 4.08#Rotatable Bonds: 2
Polar Surface Area: 43.70Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.57CX Basic pKa: 8.44CX LogP: 4.55CX LogD: 3.66
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.82Np Likeness Score: 0.60

References

1. Wilcox RE, Huang WH, Brusniak MY, Wilcox DM, Pearlman RS, Teeter MM, DuRand CJ, Wiens BL, Neve KA..  (2000)  CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.,  43  (16): [PMID:10956209] [10.1021/jm990526y]
2. Knoerzer TA, Watts VJ, Nichols DE, Mailman RB..  (1995)  Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.,  38  (16): [PMID:7636869] [10.1021/jm00016a009]

Source